Chapter III Chemical architecture of the basal ganglia

Handbook of Chemical Neuroanatomy

Volumn 15, Issue , 1999, Pages 227-284

  Graybiel, Ann M ^a   Penney, John B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001254014     PISSN: 09248196     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0924-8196(99)80025-6     Document Type: Chapter

References (360)

1. Abou-Khalil B., Young A.B., and Penney J.B. Evidence for the presynaptic localization of opiate binding sites on striatal efferent fibers. Brain Res 323 (1984) 21-29
2. 3 receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93 (1996) 1945-1949
3. Albin R.L., Aldridge J.W., Young A.B., and Gilman S. Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity. Brain Res 491 (1989) 185-188
4. Albin R.L., Makowiec R.L., Hollingsworth Z.R., Dure L.S., Penney J.B., and Young A.B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46 (1992) 35-48
5. Albin R.L., Qin Y., Young A.B., Penney J.B., and Chesselet M.F. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: An in situ hybridization study. Ann Neurol 30 (1991) 542-549
6. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
7. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of disorders of the basal ganglia. Trends Neurosci 18 (1995) 63-64
8. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., Markel D.S., Tourtellotte W.W., and Reiner A. Abnormalities of striatal projection neurons and NMDA receptors in pre-symptomatic Huntington's disease. New Eng J Med 322 (1990) 1293-1297
9. Aosaki T. Substance P excites large aspiny neurons in the rat neostriatum in vitro. IBAGS Meeting Abst. (1995)
10. Aosaki T., and Kawaguchi Y. Actions of neuropeptides on large aspiny neurons of rat neostriatum in vitro. Soc Neurosci Abstr 21 (1995) 913
11. Aosaki T., and Kawaguchi Y. Actions of substance P on rat neostriatal neurons in vitro. J Neurosci 16 (1996) 5141-5153
12. Aosaki T., Kimura M., and Graybiel A.M. Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J Neurophysiol 73 (1995) 1234-1252
13. Arenas E., Alberch J., Perez-Navarro E., Solsona C., and Marsal J. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in neostriatum. J Neurosci 11 (1991) 2332-2338
14. Augood S.J., Penney Jr. J.B., Friberg I.K., Breakefield X.O., Young A.B., Ozelius L.J., and Standaert D.G. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol 43 (1998) 669-673
15. Barbeau A., Roy M., Bernier G., Campanella G., and Paris S. Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 14 (1987) 36-41
16. Baron M.S., Vitek J.L., Bakay R., Green J., Kaneoke Y., Hashimoto T., Turner R.S., Woodward J.L., Cole S.A., McDonald W.M., and DeLong M.R. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 40 (1996) 355-366
17. Baxter Jr. L.R., Phelps M.E., Mazziota J.C., Guze B.H., Schwartz J.M., and Selin C.E. Local glucose metabolic rates in obsessive compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiat 44 (1987) 211-218
18. Baxter Jr. L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.-K., and Phelps M.E. Caudate glucose metabolic rate changes with both drug and behavioral therapy of obsessive-compulsive disorder. Arch Gen Psychiat 49 (1992) 681-689
19. Baxter L.R., Schwartz J.M., Mazziotta J.C., Phelps M.E., Pahl J.J., Guze B.H., and Fairbanks L. Cerebral glucose metabolic rates in non-depressed patients with obsessive-compulsive disorder. Am J Psychiat 145 (1988) 1560-1563
20. Beckstead R.M., Wooten G.F., and Trugman J.M. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography. J Comp Neurol 268 (1988) 131-145
21. Bell G.I., and Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci 16 (1993) 34-38
22. Benabid A.L., Pollak P., Gervason C., Hoffman D., Gao D.M., Hommel M., Perret J.E., and De Rougemont J. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337 (1991) 403-406
23. Benazzouz A., Boraud T., Feger J., Burbaud P., Bioulac B., and Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L- Dopa treatment. Mov Disord 11 (1996) 627-632
24. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., and Cohen R.M. Local cerebral glucose metabolism rates in obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiat 47 (1990) 840-848
25. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
26. Berretta S., Parthasarathy H.B., and Graybiel A.M. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 17 (1997) 4752-4763
27. Besson M.J., Graybiel A.M., and Quinn B. Co-expression of neuropeptides in the cat's striatum: An immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39 (1990) 33-58
28. 1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26 (1988) 101-119
29. Bevan M.D. Synaptic integration of functionally diverse pallidal information in the entopeduncular nucleus and subthalamic nucleus in the rat. J Neurosci 17 (1997) 308-324
30. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., and Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 94 (1997) 3363-3367
31. Bortolotto Z.A., and Collingridge G.L. Activation of glutamate metabotropic receptors induces long-term potentiation. Eur J Pharmacol 214 (1992) 297-298
32. Bowery N.G., Hudson A.L., and Price G.W. GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 20 (1987) 365-383
33. Boyd D., and Beckwith J. The role of charged amino acids in the localization of secreted and membrane proteins. Cell 62 (1990) 1031-1033
34. Breese G.R., and Traylor T.D. Depletion of brain noradrenalin and dopamine by 6-hydroxydopamine. Br J Pharmacol 42 (1971) 88-99
35. Bressman S.B., de Leon D., Brin M.F., Risch N., Burke R.E., Greene P.E., Shale H., and Fahn S. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 26 (1989) 612-620
36. 14C]GABA uptake in the basal ganglia of rats following lesions in the subthalamic region suggest a role for excitatory amino acid but not GABA-mediated transmission in subthalamic nucleus efferents. Exp Neurol 113 (1991) 171-181
37. Brouillet E., and Beal M.F. NMDA antagonists partially protect against MPTP induced neurotoxicity in mice. Neuro Report 4 (1993) 387-390
38. Brouillet E., hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., and Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92 (1995) 7105-7109
39. Burke J.R., Enghild J.J., Martin M.E., Jou Y.S., Myers R.M., Roses A.D., Vance J.M., and Strittmatter W.J. Huntington and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 2 (1996) 347-350
40. Burn D.J., Rinne J.O., Quinn N.P., Lees A.J., Marsden C.D., and Brooks D.J. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study. Brain 118 (1995) 951-958
41. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., and Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80 (1983) 546-4550
42. Calabresi P., Pisani A., Mercuri N.B., and Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 19 (1996) 19-24
43. Carpenter M.B., Whittier J.R., and Mettler F.A. Analysis of choreoid hyperkinesia in the rhesus monkey. J Comp Neurol 92 (1950) 293-332
44. 3H]glutamate binding sites. Neuroreport 4 (1993) 311-313
45. Ceballos-Baumann A.O., Obeso J.A., Vitek J.L., DeLong M.R., Bakey R., Linazasoro G., and Brooks D.J. Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 344 (1994) 814
46. Chan P., Jiang X., Forno L.S., Di Monte D.A., Tanner C.M., and Langston J.W. Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease. Neurology 50 (1998) 1136-1137
47. Chan P., Tanner C.M., Jiang X., and Langston J.W. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 50 (1998) 513-514
48. Charara A., and Parent A. Brainstem dopaminergic, cholinergic and serotoninergic afferents to the pallidum in the squirrel monkey. Brain Res 640 (1994) 155-170
49. Chase T.N., Tamminga C.A., and Burrows H. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. Adv Neurol 50 (1988) 237-241
50. Chen Q., Veenman C.L., and Reiner A. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73 (1996) 715-731
51. Chesselet M.-F., and Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci 19 (1996) 417-422
52. Chevalier G., and Deniau J.M. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 13 (1990) 277-280
53. Cicchetti F., and Parent A. Striatal interneurons in Huntington's disease: Selective increase in the density of calretinin-immunoreactive medium-sized neurons. Mov Disord 11 (1996) 619-626
54. Civelli O., Bunzow J.R., and Grandy D.K. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 32 (1993) 281-307
55. Clarke C.E., Sambrook M.A., Mitchell I.J., and Crossman A.R. Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J Neurol Sci 78 (1987) 273-280
56. Cohen L.G., and Hallett M. Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 38 (1988) 1005-1012
57. Counihan T.J., Landwehrmeyer G.B., Standaert D.G., Kosinski C.M., Scherzer C.R., Daggett L.P., Velicelebi G., Young A.B., and Penney Jr. J.B. Expression of N-methyl-d-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons. J Comp Neurol 390 (1998) 91-101
58. Crossman A.R., Mitchell I.J., and Sambrook M.A. Regional brain uptake of 2-deoxyglucose in n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacol 24 (1985) 587-591
59. Crossman A.R., Mitchell I.J., Sambrook M.A., and Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex: The site of drug action and a hypothesis for the neural mechanisms of chorea. Brain 111 (1988) 1211-1233
60. Dahlström A., and Fuxe K. Evidence for the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand 62 (1964) 1-55
61. D28k immunohistochemistry. Brain (1999)
62. in press. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain (1999)
63. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Magniarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
64. de Montis G., Beaumont K., Javoy-Agid F., Agid Y., Constandinidis J., Lowenthal A., and Lloyd K.G. Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding. J Neurochem 38 (1982) 718-724
65. DeBoer P., and Abercrombie E.D. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J Pharmacol Exp Ther 277 (1996) 775-783
66. Difazio M.C., Hollingsworth Z., Young A.B., and Penney Jr. J.B. Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology 42 (1992) 402-406
67. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci 13 (1990) 286-289
68. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
69. Ding Y.Q., Shigemoto R., Takada M., Ohishi H., Nakanishi S., and Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol 364 (1996) 290-310
70. Dogali M., Fazzini E., Kolodny E., Eidelberg D., Sterio D., Devinsky O., and Beric A. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 45 (1995) 753-761
71. 1A dopamine receptors. Proc Natl Acad Sci USA 91 (1994) 12564-12568
72. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J Neurosci 12 (1992) 3628-3641
73. Dube L., Smith A.D., and Bolam J.P. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum. J Comp Neurol 267 (1988) 455-471
74. Dure L.S., Young A.B., and Penney J.B. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease. Ann Neurol 30 (1991) 785-793
75. Dure L.S., Young A.B., and Penney J.B. Compartmentalization of excitatory amino acid receptors in human striatum. Proc Natl Acad Sci USA 89 (1992) 7688-7692
76. Duvoisin R.C., and Golbe L.I. Kindreds of dominantly inherited Parkinson's disease: keys to the riddle [editorial; comment]. Ann Neurol 38 (1995) 355-356
77. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., Folstein S., Ross C., Franz M., Abbott M., Gray J., Conneally P., Young A., Penney J., Hollingsworth Z., Shoulson I., Lazzarini A., Falek A., Koroshetz W., Sax D., Bird E., Vonsattel J., Bonilla E., and MacDonald M. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet 4 (1993) 387-392
78. Duyao M.P., Auerbach A.B., Ryan A., Persichetti F., Barnes G.T., McNeil S.M., Ge P., Vonsattel J.P., Gusella J.F., Joyner A.L., and Macdonald M.E. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269 (1995) 407-410
79. Eberle-Wang K., Mikeladze Z., Uryu K., and Chesselet M.F. Pattern of expression of the serotonin2C receptor mesenger RNA in the basal ganglia of adult rats. J Comp Neurol 384 (1997) 233-247
80. Eblen F., and Graybiel A.M. Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J Neurosci 15 (1995) 5999-6013
81. Ehringer H., and Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen System. Wien Klin Wochenschr 38 (1960) 1236-1239
82. Eidelberg D., Moeller J.R., Ishikawa T., Dhawar V., Spetsieris P., Przedborski S., and Fahn S. The metabolic topography of idiopathic torsion dystonia. Brain 118 (1995) 1473-1484
83. Faull R.L.M., Glass M., and Dragunow M. Comparative study of cannabinoid, dopamine and adenosine receptor alterations in the human basal ganglia in Huntington's disease. 17th Intl Meeting, World Federation of Neurology Research Groups on Huntington's Disease 23 (1997)
84. Feger J., Bevan M., and Crossman A.R. The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labeling study. Neuroscience 60 (1994) 125-132
85. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., Macdonald M.E., Beal M.F., and Hersch S.M. Heterogeneous topographic and cellular distribution of Huntington expression in the normal human neostriatum. J Neurosci 17 (1997) 3052-3063
86. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., and Richardson Jr. E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46 (1987) 12-27
87. Ferre S., O'Connor W.T., Fuxe K., and Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci 13 (1993) 5402-5406
88. Fiorillo C.D., and Williams J.T. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature 394 (1998) 78-82
89. Flaherty A.W., and Graybiel A.M. Output architecture of the primate putamen. J Neurosci 13 (1993) 3222-3237
90. Flaherty A.W., and Graybiel A.M. Two input systems for body representations in the primate striatal matrix: Experimental evidence in the squirrel monkey. J Neurosci 13 (1993) 1120-1137
91. Flaherty A.W., and Graybiel A.M. Anatomy of the basal ganglia. In: Marsden C.D., and Fahn S. (Eds). Movement Disorders 3 (1994), Butterworths, London 3-27
92. Flaherty A.W., and Graybiel A.M. Input-output organization of the sensorimotor striatum in the squirrel monkey. J Neurosci 14 (1994) 599-610
93. Flaherty A.W., and Graybiel A.M. Motor and somatosensory corticostriatal projection magnifications in the squirrel monkey. J Neurophysiol 74 (1995) 2638-2648
94. Fox C.A., Andrade R., Schwyn R.C., and Rafols J.A. The aspiny neurons and the glia in the primate striatum: A golgi and electron microscopic study. J Hirnforsch 13 (1971) 341-362
95. Francois C.J.Y.G.P.D.T. Calbindin D-28k as a marker for the associative cortical territory of the striatum in macaque. Brain Res 633 (1994) 331-336
96. Freedman S.B., Patel S., Marwood R., Emms F., Seabrook G.R., Knowles M.R., and McAllister G. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther 268 (1994) 417-426
97. Futami T., Takakusaki K., and Kitai S.T. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopaminergic neurons in the substantia nigra, pars compacta. Neurosci Res 21 (1995) 331-342
98. Garcia-Rill E. The basal ganglia and the locomotor regions. Brain Res 396 (1986) 47-63
99. Garcia-Rill E. The pedunculpontine nucleus. Prog Neurobiol 36 (1991) 363-389
100. Gerfen C.R. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res 556 (1991) 165-170
101. 2 dopamine receptor regulation of striatonigral and striatopallidal neurons. Semin Neurosci 4 (1992) 109-118
102. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15 (1992) 133-139
103. Gerfen C.R., Baimbridge K.G., and Miller J.J. The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 82 (1985) 8780-8784
104. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
105. Ghazemzadeh M., Sharma S., Surmeier D., Eberwine J., and Chesselet M. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol Pharmacol 49 (1996) 852-859
106. Giménez-Amaya J.M., and Graybiel A.M. Compartmental origins of the striatopallidal projection in the primate. Neuroscience 34 (1990) 111-126
107. Giménez-Amaya J.-M., and Graybiel A.M. Modular organization of projection neurons in the matrix compartment of the primate striatum. J Neurosci 11 (1991) 779-791
108. Gingrich J.A., and Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 16 (1993) 299-321
109. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
110. Glass M., Brotchie J.M., and Maneuf Y.P. Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur J Neurosci 9 (1997) 199-203
111. Goldberg Y.P., Nicholson D.W., Rasper D.M., Kalchman M.A., Koide H.B., Graham R.K., Bromm M., Kazemi-Esfarjani P., Thornberry N.A., Vaillancourt J.P., and Hayden M.R. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 13 (1996) 442-449
112. Gonzales C.L., KD J., TA F., and CM. Distribution of glutamic acid decarboxylase M-R 67000 in the basal ganglia of the rat: an immunohistochemical study with a selective cDNA-generated polyclonal antibody. J Neurocytol 20 (1991) 953-961
113. Gonzales C., Lin R.C., and Chesselet M.F. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neurosci Lett 135 (1992) 53-58
114. Graveland G.A., and DiFiglia M. The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res 327 (1985) 307-311
115. Graybiel A.M. Organization of the nigrotectal connection: An experimental tracer study in the cat. Brain Res 143 (1978) 339-348
116. Graybiel A.M. Neurochemically specified subsystems in the basal ganglia. In: Evered D., and O'Connor M. (Eds). Functions of the Basal Ganglia. Ciba Foundation Symposium 107 (1984), Pitman, London 114-149
117. Graybiel A.M. Neuropeptides in the basal ganglia. In: Martin J.B., and Barchas J.D. (Eds). Neuropeptides in Neurologic and Psychiatric Disease (1986), Raven Press, New York 135-161
118. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13 (1990) 244-254
119. Graybiel A.M. Functions of the nigrostriatal system. Clin Neurosci 1 (1993) 12-17
120. Graybiel A.M. Building action repertoires: Memory and learning functions of the basal ganglia. Curr Opin Neurobiol 5 (1995) 733-741
121. Graybiel A.M. Basal ganglia: New therapeutic approaches to Parkinson's disease. Current Biol 6 (1996) 368-371
122. Graybiel A.M. The basal ganglia and cognitive pattern generators. Schizophren. Bull. 23 (1997) 459-469
123. Graybiel A.M. The basal ganglia and chunking of action repertoires. Neurobiology of Learning and Memory 70 (1998) 119-136
124. Graybiel A.M., Aosaki T., Flaherty A.W., and Kimura M. The basal ganglia and adaptive motor control. Science 265 (1994) 1826-1831
125. Graybiel A.M., Baughman R.W., and Eckenstein F. Cholinergic neuropil of the striatum observes striosomal boundaries. Nature 323 (1986) 625-627
126. Graybiel A.M., and Chesselet M.-F. Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. Proc Natl Acad Sci USA 81 (1984) 7980-7984
127. Graybiel A.M., Hirsch E.C., and Agid Y. The nigrostriatal system in Parkinson's disease. In: Streifler M.B., Korczyn A.D., Melamed E., and Youdim M.B.H. (Eds). Parkinson's Disease: Anatomy, Pathology, and Therapy Vol. 53 (1990), Raven Press, New York 17-29
128. Graybiel A.M., and Kimura M. Adaptive neural networks in the basal ganglia. In: Houk J.C., Davis J.L., and Beiser D.G. (Eds). Models of Information Processing in the Basal Ganglia (1995), M.I.T. Press, Cambridge 103-116
129. Graybiel A.M., and Moratalla R. Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc Natl Acad Sci USA 86 (1989) 9020-9024
130. Graybiel A.M., and Ragsdale Jr. C.W. Biochemical anatomy of the striatum. In: Emson P.C. (Ed). Chemical Neuroanatomy (1983), Raven Press, New York 427-504
131. Graybiel A.M., and Ragsdale Jr. C.W. Histochemically distinct compartments in the striatum of human, monkey, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci USA 75 (1978) 5723-5726
132. Greenamyre J.T., Penney J.B., Young A.B., D'Amato C.J., Hicks S.P., and Shoulson I. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227 (1985) 1496-1499
133. Gutekunst C.A., Levey A.I., Heilman C.J., Whaley W.L., Yi H., Nash N.R., Rees H.D., Madden J.J., and Hersch S.M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A 92 (1995) 8710-8714
134. Haber S.N., Kowall N.W., Vonsattel J.P., Bird E.D., and Richardson Jr. E.P. Gilles de la Tourette's syndrome: A postmortem neuropathological and immunohistochemical study. J Neurol Sci 75 (1986) 225-241
135. Haber S.N., Kunishio K., Mizobuchi M., and Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 15 (1995) 4851-4867
136. Haber S.N., Lynd-Balta E., and Spooren W.P.J.M. Integrative aspects of basal ganglia circuitry. In: Percheron G., McKenzie J.S., and Feger J. (Eds). The Basal Ganglia IV: New Ideas and Data on structure and Function (1993), Plneum, New York 71-80
137. Haber S.N. The organization of the descending ventral pallidal projections in the monkey. J Comp Neurol 329 (1993) 111-128
138. Harrington K.A., Augood S.J., Faull R.L., McKenna P.J., and Emson P.C. Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study. Brain Res Mol Brain Res 33 (1995) 333-342
139. Hayden M.R., Martin W.R., Stoessl A.J., Clark C., Hollenberg S., Adam M.J., Ammann W., Harrop R., Rogers J., Ruth T., Sayre C., and Pate B.D. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 36 (1986) 888-894
140. Hedreen J.C., and Folstein S.E. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp. Neurol 54 (1995) 105-120
141. Heikkila R.E., Manzino L., Cabbat F.S., and Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311 (1984) 467-469
142. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 23 (1987) 1-38
143. Herkenham M., Lynn A.B., De Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547 (1991) 267-274
144. Herrling P.L. Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate- or kainate-receptors. Neuroscience 14 (1985) 417-426
145. Hersch S.M., Ciliax B.J., Gutenkunst C.-A., Rees H.D., Heilman C.J., Yung K.K.L., Bolam J.P., Ince E., Yi H., and Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor cortical afferents. J Neurosci 15 (1995) 5222-5237
146. Hersch S.M., Gutekunst C.A., Rees H.D., Heilman C.J., and Levey A.I. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14 (1994) 3351-3363
147. Hikosaka O., and Wurtz R.H. Visual and oculomotor functions of monkey Macaca mulatta substantia nigra, pars reticulata. 1. Relation of visual and auditory responses to saccades. J Neurophysiol 49 (1983) 1230-1253
148. Hikosaka O., and Wurtz R.H. Visual and oculomotor functions of monkey Macaca mulatta substantia nigra, pars reticulata. 2. Visual responses related to fixation of gaze. J Neurophysiol 49 (1983) 254-1267
149. Hikosaka O., and Wurtz R.H. Visual and oculomotor functions of monkey Macaca mulatta substantia nigra, pars reticulata. 3. Memory contingent visual and saccade responses. J. Neurophysiol 49 (1983) 1268-1284
150. Hikosaka O., and Wurtz R.H. Visual and oculomotor functions of monkey Macaca mulatta substantia nigra, pars reticulata. 4. Relation of substantia nigra to superior colliculus. J Neurophysiol 49 (1983) 1285-1301
151. Hirsch E., Graybiel A.M., and Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
152. Hirsh R. The hippocampus and contextual retrieval of information from memory: a theory. Behavioral Biol 12 (1974) 421-444
153. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17 (1994) 31-108
154. Holt D.J., Graybiel A.M., Hyde T.M., Herman M.M., Kleinman J.E., German D.C., and Saper C.B. Decreased density of cholinergic interneurons in the striatum of schizophrenic. Soc Neurosci Abstr 20 (1994) 784
155. Holt D.J., Graybiel A.M., and Saper C.B. Neurochemical architecture of the human striatum. J Comp Neurol 384 (1997) 1-25
156. (submitted). Holt D.J., Herman M.M., Hyde T.M., Klienman J.E., Sinton C.M., German D.C., Hersh L.B., Graybiel A.M., and Saper C.B. Evidence for a deficit in cholinergic interneurons in the striatum of schizophrenics. Neuroscience (1999)
157. Houk J.C. Information processing in modular circuits linking basal ganglia and cerebral cortex. In: Houk J.C., Davis J.L., and Beiser D.G. (Eds). Models of Information Processing in the Basal Ganglia (1995), M.I.T. Press, Cambridge, U.S.A. 3-10
158. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P., O'Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E., and Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16 (1995) 86-88
159. Hoyer D., Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376 (1986) 85-96
160. Hoyer D., Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376 (1986) 97-107
161. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
162. Hyde T.M., and Weinberger D.R. Tourette's syndrome: a model neuropsychiatric disorder. N Eng J Med 273 (1995) 498-501
163. Iacono R.P., Lonser R.R., Mandybur G., Morenski J.D., Yamada S., and Shima F. Stereotactic pallidotomy results for Parkinson's exceed those of fetal graft. American Surgeon 60 (1994) 777-782
164. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S., Fujita K., and Nagatsu T. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature Genet 8 (1994) 236-242
165. Ikoma K., Samii A., Mercuri B., Wassermann E.M., and Hallett M. Abnormal cortical motor excitability in dystonia. Neurology 46 (1996) 1371-1376
166. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., and Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57 (1998) 334-337
167. Iversen L.L., Reynolds G.P., and Snyder S.H. Pathophysiology of schizophrenia-causal role for dopamine or noradrenaline?. Nature 305 (1983) 577-578
168. Jackson A., and Crossman A.R. Experimental choreoathetosis produced by injection of a gamma- aminobutyric acid antagonist into the lentiform nucleus in the monkey. Neurosci Lett 46 (1984) 41-45
169. Javitch J.A., and Snyder S.H. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur J Pharmacol 106 (1984) 455-456
170. Joel D., and Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience 63 (1994) 363-379
171. Joel D., and Weiner I. The connections of the primate subthalamic nucleus: indirect pathways and the open interonnected scheme of basal ganglia thalamocortical circuitry. Brain Res Rev 23 (1997) 62-78
172. Julius D. Molecular biology of serotonin receptors. Annu Rev Neurosci 14 (1991) 335-360
173. Kaupmann K., Huggel K., Heid J., Flor P.J., Bischoff S., Mickel S.J., McMaster G., Angst C., Bittiger H., Froestl W., and Bettler B. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386 (1997) 239-246
174. Kawaguchi Y., Aosaki T., and Kubota Y. Cholinergic and GABAergic interneurons in the striatum. Nihon Shinkei Seishin Yakurigaku Zasshi 17 (1997) 87-90
175. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18 (1995) 527-535
176. Keegan K.D., Woodruff G.N., and Pinnock R.D. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra, pars compacta in vitro. Br J Pharmacol 105 (1992) 3-5
177. Kemp J.A., and Powell T.P.S. The structure of the caudate nucleus of the cat: light and electron microscopy. Phil Trans R Soc Lond [Biol.] 262 (1971) 383-401
178. Kerner J.A., Standaert D.G., Penney Jr. J.B., Young A.B., and Landwehrmeyer G.B. Expression of group II and III mGluR mRNAs in identified striatal and cortical neurons. Soc Neurosci Abstr 23 (1997) 938
179. Kim J.S., Hassler R., Hau P., and Paik K.S. Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Res 132 (1977) 370-374
180. Kincaid A.E., and Wilson C.J. Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol 374 (1996) 578-592
181. Kindt M.V., Nicklas W.J., Sonsalla P.K., and Heikkila R.E. Mitochondria and the neurotoxicity of MPTP. Trends Pharmacol Sci 7 (1986) 473-475
182. Kish S.J., Shannak K., and Hornykiewicz O. Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease-pathophysiologic and clinical implications. N Eng J Med 318 (1988) 876-880
183. Kita H., Chang H.T., and Kitai S.T. Pallidal inputs to subthalamus: intracellular analysis. Brain Res 264 (1983) 255-265
184. Kita H., and Kitai S.T. Amygdaloid projections to the frontal cortex and the striatum in the rat. J Comp Neurol 298 (1990) 40-49
185. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 605-608
186. Kitai S.T., and Deniau J.M. Cortical inputs to the subthalamus: intracellular analysis. Brain Res 214 (1981) 411-415
187. Kitai S.T., and Kita H. Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In: Carpenter M.B., and Jayaraman a. (Eds). The Basal Ganglia II: Structure and Function-Current Concepts (1987), Plenum Press, New York 357-373
188. Klawans H.L. The pathophysiology of drug-induced movement disorders. In: Jankovic J., and Tolosa E. (Eds). Parkinson's disease and Movement Disorders (1988), Urban and Schwarzenberg, Baltimore 315-326
189. Knowlton B.J., Mangels J.A., and Squire L.R. A neostriatal habit learning system in humans. Science 273 (1996) 1399-1402
190. Kojima J., Yamaji Y., Matsumura M., Nambu A., Inase M., Tokuno H., Takada M., and Imai H. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci Lett 226 (1997) 111-114
191. Koller W., Vetere-Overfield B., Gray C., Alexander C., Chin T., Dolezal J., Hassanein R., and Tanner C. Environmental risk factors in Parkinson's disease. Neurology 40 (1990) 1218-1221
192. Kosinski C.M., Cha J.H., Young A.B., Persichetti F., MacDonald M., Gusella J.F., Penney Jr. J.B., and Standaert D.G. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp Neurol 144 (1997) 239-247
193. Kosinski C.M., Standaert D.G., Counihan T.J., Scherzer C.R., Kerner J.A., Daggett L.P., Velicelebi G., Penney J.B., Young A.B., and Landwehrmeyer G.B. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus. J Comp Neurol 390 (1998) 63-74
194. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nature Genet 18 (1998) 106-108
195. Kuhl D.E., Metter E.J., Riege W.H., and Markham C.H. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol 15 Suppl (1984) S119-S125
196. Kuhl D.E., Phelps M.E., Markham C.H., Metter E.J., Riege W.H., and Winter J. Local cerebral glueose utilization in Huntington's disease determined by emission computed tomography of [18]FDG. Ann Neurol 12 (1982) 425-434
197. Laihinen A.O., Rinne J.O., Ruottinen H.M., Nagren K.A., Lehikoinen P.K., Oikonen V.J., Ruotsalainen U.H., and Rinne U.K. PET studies on dopamine D1 receptors in the human brain with carbon-11- SCH 39166 and carbon-11-NNC 756. J Nucl Med 35 (1994) 1916-1920
198. Laitinen L.V., Bergenheim A.T., and Hariz M.I. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76 (1992) 53-61
199. Laitinen L.V., Bergenheim A.T., and Hariz M.I. Ventroposterolateral pallidotomy can abolish all Parkinsonian symptoms. Stereotact Funct Neurosurg 58 (1992) 14-21
200. Landwehrmeyer B., Mengod G., and Palacios J.M. Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18 (1993) 187-192
201. Landwehrmeyer G.B., McNeil S.M., Dure L.S., Ge P., Aizawa H., Huang Q., Ambrose C.M., Duyao M.P., Bird E.D., Bonilla E., De Young M., Avila-Gonzales A.J., Wexler N.S., DiFiglia M., Gusella J.F., Macdonald M.E., Penney J.B., Young A.B., and Vonsattel J.P. Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37 (1995) 218-230
202. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney Jr. J.B., and Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 15 (1995) 5297-5307
203. Lang A.E., Lozano A.M., Montgomery E., Duff J., Tasker R., and Hutchison W. Posteroventral medial pallidotomy in advanced Parkinson's disease. New Eng J Med 337 (1997) 1036-1042
204. Lange K.W., Wells F.R., Jenner P., and Marsden C.D. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J Neurochem 60 (1993) 197-203
205. Langer L.F., and Graybiel A.M. Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res 498 (1989) 344-350
206. Langston J., Ballard P., Tetrud J., and Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
207. Lavoie B., and Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp Neurol 299 (1990) 1-16
208. Lazzarini A.M., Myers R.H., Zimmerman Jr. T.R., Mark M.H., Golbe L.I., Sage J.I., Johnson W.G., and Duyoisin R.C. A clinical genetic study of Parkinson's disease: Evidence for dominant transmission. Neurology 44 (1994) 499-506
209. Leckman J.F., Knorr A.M., Rasmusson A.M., and Cohen D.J. Basal ganglia research and Tourette's syndrome. Trends Neurosci 14 (1991) 94-95
210. Lee T., Seeman P., Rajput A., Farley I., and Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in parkinson's disease. Nature 273 (1978) 59-61
211. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., Ruberg M., Asensi H., Agid Y., Feger Y., Obeso J.A., Parent A., and Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 76 (1997) 335-343
212. Lewis D.A., and Sesack S.R. Dopamine systems in the primate brain. In: Bloom F.E., Björklund A., and Hökfelt T. (Eds). Handbook of Chemical Neuroanatomy: The Primate Nervous System, Part I (1997), Elsevier, Amsterdam 263-375
213. Li S.-H., Schilling G., Young III W.S., Li X.-J., Margolis R.L., Stine O.C., Wagster M.V., Abbott M.H., Franz M.L., Ranen N.G., Folstein S.E., Hedreen J.C., and Ross C.A. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11 (1993) 985-993
214. Li X.J., Sharp A.H., Li S.H., Dawson T.M., Snyder S.H., and Ross C.A. Huntingtin-associated protein (HAP1): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc Natl Acad Sci USA 93 (1996) 4839-4844
215. Li X.-J., Li S.-H., Sharp A.H., Nucifora Jr. F.C., Schilling G., Lanahan A., Worley P., Snyder S.H., and Ross C.A. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378 (1995) 398-402
216. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., and Benabid A.L. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345 (1995) 91-95
217. Lozano A.M., Lang A.E., Galvez-Jiminez N., Miyasaki J., Duff J., and Hutchinson W.D. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 346 (1995) 1383-1387
218. Ludecke B., Dworniczak B., and Bartholome K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 95 (1995) 123-127
219. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annu. Rev. Neurosci. 17 (1994) 569-602
220. Maeno H., Kiyama H., and Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Brain Res Mol Brain Res 18 (1993) 43-58
221. 123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiat 152 (1995) 1359-1361
222. Maneuf Y.P., Mitchell I.J., Crossman A.R., Brotchie J.M., and Gage F.H. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol 125 (1994) 65-71
223. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Heterington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., and Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 (1996) 493-506
224. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hydridization study. J Comp Neurol 350 (1994) 412-438
225. Marsden C.D., Obeso J.A., Zarranz J.J., and Lang A.E. The anatomical basis of symptomatic hemidystonia. Brain 108 (1985) 463-483
226. Martin L.J., Hadfield M.G., Dellovade T.L., and Price D.L. The striatal mosaic in primates: patterns of neuropeptide immunoreactivity differentiate the ventral stiatum from the dorsal striatum. Neuroscience 43 (1991) 397-417
227. Matsumoto M., Hidaka K., Tada S., Tasaki Y., and Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem 66 (1996) 915-919
228. Mazziotta J.C., Phelps M.E., Pahl J.J., Huang S.C., Baxter L.R., Riege W.H., Hoffman J.M., Kuhl D.E., Lanto A.B., Wapenski J.A., and Markhan C.H. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med 316 (1987) 357-362
229. 2 dopamine receptor mRNA in rat brain. Neurospychopharmacol 5 (1991) 231-242
230. Mercuri N.B., Bonci A., Pisani A., Calabresi P., and Bernardi G. Actions of glycine on non-dopaminergic neuron of the rat substantia nigra. Eur J Neurosci 7 (1995) 2351-2354
231. Middleton F.A., and Strick P.L. The temporal lobe is a target of output of the basal ganglia. Proc Natl Acad Sci USA 93 (1996) 8683-8687
232. Mink J.W. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 50 (1996) 381-425
233. Mishkin M., Malamut B., and Bachevalier J. Memories and habits: Two neural systems. In: Lynch G., McGaugh J.L., and Weinberger N.M. (Eds). Neurobiology of Human Learning and Memory (1984), Guilford Press, New York 65-77
234. Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., and Crossman A.R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine. Neuroscience 32 (1989) 213-226
235. Mitchell S.J., Richardson R.T., Baker E.H., and DeLong M.R. The primate globus pallidus: neuronal activity related to direction of movement. Exp Brain Res 68 (1987) 491-505
236. Moratalla R., Quinn B., Delanney L.E., Irwin I., Langston J.W., and Graybiel A.M. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 89 (1992) 3859-3863
237. Moriyoshi K., Masu M., Ishii T., Shigemoto R., Mizuno N., and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 354 (1991) 31-37
238. Murray A.M., Hyde T.M., Kanble M.B., Herman M.M., Bigelow L.B., Carter J.M., Weinberger D.R., and Kleinman J.E. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 15 (1995) 2186-2191
239. Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci 14 (1991) 123-136
240. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 258 (1992) 597-603
241. Nambu A., Takada M., Inase M., and Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 16 (1996) 2671-2683
242. Nasir J., Floresco S.B., O'Kusky J.R., Diewert V.M., Richman J.M., Zeisler J., Borowski A., Marth J.D., Phillips A.G., and Hayden M.R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81 (1995) 811-823
243. Nicholas A.P., Pieribone V., and Hökfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328 (1993) 575-594
244. Nisenbaum E.S., Xu Z.C., and Wilson C.J. Contribution of a slowly inactivating potassium current to the transition to firing of neostriatal spiny projection neurons. J Neurophysiol 71 (1994) 1174-1189
245. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307 (1984) 462-465
246. Ohye C. Neural circuits involved in parkinsonian motor disturbance studied in monkeys. Eur Neurol 26 suppl. 1 (1987) 41-46
247. Onn S.P., and Grace A.A. Dye coupling between rat striatal neurons recorded in vivo: compartmental organization and modulation by dopamine. J Neurophysiol 71 (1994) 1917-1934
248. Orlando L.R., Standaert D.G., Penney Jr. J.B., and Young A.B. Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3- hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neurosci Lett 202 (1995) 109-112
249. Ottersen O.P., and Landsend A.S. Organization of glutamate receptors at the synapse. Eur J Neurosci 9 (1997) 2219-2224
250. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., Fahn S., Risch N.J., Buckler A.J., Gusella J.F., and Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genet 17 (1997) 40-48
251. Palacios J.M., Rigo M., Chinaglia G., and Probst A. Reduced density of striatal somatostatin receptors in Huntington's chorea. Brain Res 522 (1990) 342-346
252. Parent A., Cicchetti F., and Beach T.G. Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates. Neuro Report 6 (1995) 721-724
253. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 20 (1995) 91-127
254. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20 (1995) 128-154
255. Parthasarathy H.B., and Graybiel A.M. Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J Neurosci 17 (1997) 2477-2491
256. Parthasarathy H.B., Schall J.D., and Graybiel A.M. Distributed but convergent ordering of corticostriatal projections: Analysis of the frontal eye field and the supplementary eye field in the macaque monkey. J Neurosci 12 (1992) 4468-4488
257. Pauls D.L., and Leckman J.F. The genetics of Tourette's syndrome. In: Cohen D.J., Bruun R.D., and Leckman J.F. (Eds). Tourette's Syndrome and Tic Disorders (1988), John Wiley & Sons, New York 91-101
258. Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21 (1987) 97-122
259. Pazos A., Probst A., and Palacios J.M. Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21 (1987) 123-139
260. Penney J.B., and Pan H.S. Quantitative autoradiography of GABA and benzodiazepine binding in studies of mammalian and human basal ganglia function. In: Boast C., Snowhill E.W., and Altar C.A. (Eds). Quantitative Receptor Autoradiography (1986), Alan Liss, New York 29-52
261. Penney Jr. J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., and Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 41 (1997) 689-692
262. Penney Jr. J.B., and Young A.B. Quantitative autoradiography of neurotransmitter receptors in Huntington disease. Neurology 32 (1986) 1391-1395
263. Penney Jr. J.B., and Young A.B. Striatal inhomogeneities and basal ganglia function. Move Dis 1 (1986) 3-15
264. Penney Jr. J.B., Young A.B., Walker F.O., and Shoulson I. Quantitative Autoradiography of Opiate Receptors in Huntington's and Parkinson's Disease. Neurology 34 (1984) 153
265. Percheron G., Francois C., Yelnik J., Fenelon G., and Talbi B. The basal ganglia related system of primates: Definition, description and informational analysis. In: Percheron G., McKenzie J.S., and Feger J. (Eds). The Basal Ganglia IV: New Ideas and Data on Structure and Function (1992), Plenum, New York 3-20
266. Perry E.K., Perry R.H., Smith C.J., Dick D.J., Candy J.M., Edwardson J.A., Fairbairn A., and Blessed G. Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiat 50 (1987) 806-809
267. Peterfreund R.A., MacCollin M., Gusella J., and Fink J.S. Characterization and expression of the human A2a adenosine receptor gene. J Neurochem 66 (1996) 362-368
268. Peterson B., Riddle M.A., Cohen D.J., Katz L.D., Smith J.C., Hardin M.T., and Leckman J.F. Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images. Neurology 43 (1993) 941-949
269. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
270. Potenza M.N., Graminski G.F., Schmauss C., and Lerner M.R. Functional expression and characterization of human D2 and D3 dopamine receptors. J Neurosci 14 (1994) 1463-1476
271. Ragsdale Jr. C.W., and Graybiel A.M. Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J Comp Neurol 269 (1988) 506-522
272. Rajput A.H., Uitti R.J., Stern W., and Laverty W. Early onset Parkinson's disease in Saskatchewan-environmental considerations for etiology. Can J Neurol Sci 13 (1986) 312-316
273. Reilly J.A., Hallett M., Cohen L.G., Tarkka I.M., and Dang N. The N30 component of somatosensory evoked potentials in patients with dystonia. Electroencephalogr Clin Neurophysiol 84 (1992) 243-247
274. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., and Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci USA 85 (1988) 5733-5737
275. Reisine T.D., Fields J.Z., Stern L.Z., Johnson P.C., Bird E.D., and Yamamura H.I. Alterations in dopaminergic receptors in Huntington's disease. Life Sci 21 (1977) 1123-1128
276. Reubi J.C., Cortes R., Maurer R., Probst A., and Palacios J.M. Distribution of somatostatin receptors in the human brain: an autoradiographic study. Neuroscience 18 (1986) 329-346
277. Reznikoff G.A., Manaker S., Rhodes C.H., Winokur A., and Rainbow T.C. Localization and quantification of beta-adrenergic receptors in human brain. Neurology 36 (1986) 1067-1073
278. Richfield E., A., Mzk E., Vh P., and V. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38 (1995) 852-861
279. Richfield E.K., and Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36 (1994) 577-584
280. Richfield E.K., Penney J.B., and Young A.B. Anatomical and affinity state comparisons between dopanine D1 and D2 receptors in the rat central nervous system. Neuroscience 30 (1989) 767-777
281. Richfield E.K., Young A.B., and Penney J.B. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pieons, rats, cats, and monkeys. J Comp Neurol 262 (1987) 446-463
282. 11C] raclopride. J Neurol Sci 132 (1995) 156-161
283. Rinne J.O., Rinne J.K., Laakso K., Lonnberg P., and Rinne U.K. Dopamine D-1 receptors in the parkinso nian brain. Brain Res 359 (1985) 306-310
284. Rinne U.K., Laihinen A., Rinne J.O., Nagren K., Bergman J., and Ruotsalainen U. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the straitum of patients with early Parkinson's disease. Mov Disord 5 (1990) 55-59
285. Robertson G.S., and Robertson H.A. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J Neurosci 9 (1989) 3326-3331
286. Robertson R.G., Clarke C.E., Boyce S., Sambrook M.A., and Crossman A.R. GABA/benzodiazepine receptors in the primate basal ganglia following treatment with MPTP: Evidence for the differential regulation of striatal output by dopamine?. In: Crossman A.R., and Sambrook M.A. (Eds). Neural Mechanisms in Disorders of Movement (1989), John Libbey, London 165-174
287. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Carbbe J.C., Nestler E.J., and Hen R. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393 (1998) 175-178
288. 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Arch Gen Psychiat 49 (1992) 695-702
289. Salmon D.P., and Butters N. Neurobiology of skill and habit learing. Curr Opin Neurobiol 5 (1995) 184-190
290. Sapp E., Ge P., Aizawa H., Bird E., Penney J.B., Young A.B., Vonsattel J.P., and DiFiglia M. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64 (1995) 397-404
291. Sato F., Levesque M., Nakamura Y., and Parent A. Axonal projections of single cells from the external pallidum in monkeys. Soc Neurosci Abstr 23 (1997) 196
292. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., and Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptors. Science 265 (1994) 1875-1878
293. Sawle G.V., Hymas N.F., Lees A.J., and Frackowiak R.S.J. Obsessional slowness. Functional studies with positron emission tomography. Brain 114 (1991) 2191-2202
294. Schiffmann S.N., Libert F., Vassart G., and Vanderhaeghen J.J. Distribution of adenosine A2 receptor mRNA in the human brain. Neurosci Lett 130 (1991) 177-181
295. Schirmer E.C., Glover J.R., Singer M.A., and Lindquist S. HSP 100/Clp proteins: a common mechanism explains diverse functions. Trends Biochem. Sci. 21 (1996) 289-296
296. Schultz W. Dopamine neurons and their role in reward mechanism. Curr Opin Neurobiol. 7 (1997) 191-197
297. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1595-1599
298. Schwartz J.M., Stoessel P.W., Baxter Jr. L.R., Martin K.M., and Phelps M.E. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiat 53 (1996) 109-113
299. A receptor family: molecular and functional diversity. Cold Spring Harb Symp Quant Biol 55 (1990) 29-40
300. Segawa M., Hosaka A., Miyagawa F., Nomura Y., and Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 14 (1976) 215-233
301. Shink E., Bevan M.D., Bolam J.P., and Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnnected structures that control the output of the basal ganglia in the monkey. Neuroscience 73 (1996) 335-357
302. Siegfried J., and Lippitz B. Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35 (1994) 126-129
303. Singer H.S., Hahn I.-H., and Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30 (1991) 558-562
304. Smith Y., Wichmann T., and DeLong M.R. Synaptic innervation of neurones in the internal pallidal segment by the subthalamic nucleus and the external pallidum in monkeys. J Comp Neurol 343 (1994) 297-318
305. 3) as a target for neuroleptics. Nature 347 (1990) 146-151
306. Sommer B., Kohler M., Sprengel R., and Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67 (1991) 11-19
307. Spillantini M.G., Schmidt M.L., Lee F., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
308. Spooren W.P., Lynd-Balta E., Mitchell S., and Haber S.N. Ventral pallidostriatal pathway in the monkey: evidence for modulation of basal ganglia circuits. J Comp Neurol 370 (1996) 295-312
309. Staines W.A., and Fibiger H.C. Collateral projections of neurons of the rat globus pallidus to the striatum and substantia nigra. Exp Brain Res 56 (1984) 217-220
310. Standaert D.G., Testa C.M., Young A.B., and Penney Jr. J.B. Organization of N-methyl-d-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343 (1994) 1-16
311. Starosta-Rubinstein S., Young A.B., Kluin K., Hill G., Aisen A.M., Gabrielsen T., and Brewer G.J. Clinical assesment of 31 patients with Wilson's disease: Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44 (1987) 365-370
312. Stern-Bach Y., Bettler B., Hartley M., Sheppard P.O., O'Hara P.J., and Heinemann S.F. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron 13 (1994) 1345-1357
313. Stoessl A.J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res 646 (1994) 13-18
314. Stoessl A.J., Szczutkowski E., Glenn B., and Watson I. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions. Brain Res 565 (1991) 254-262
315. Strong T.V., Tagle D.A., Valdes J.M., Elmer L.W., Boehm K., Swaroop M., Kaatz K.W., Collins F.S., and Albin R.L. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet 5 (1993) 259-265
316. Suarez J.I., Metman L.V., Reich S.G., Dougherty P.M., Hallett M., and Lenz F.A. Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol 42 (1997) 807811
317. Surmeier D.J., Eberwine J., Wilson C.J., Cao Y., Stefani A., and Kitai S.T. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 89 (1992) 10178-10182
318. Surmeier D.J., Reiner A., Levine M.S., and Ariano M.A. Are neostriatal dopamine receptors co-localized?. Trends Neurosci 16 (1993) 299-305
319. Surmeier D.J., Song W.J., and Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16 (1996) 6579-6591
320. Svennilson E., Torvik A., Lowe R., and Leksell L. Treatment of Parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr Neurol Scand 35 (1960) 358-377
321. Swedo S.E., Pietrini P., Leonard H.L., Schapiro M.B., Rettew D.C., Goldberger E.L., Rapoport S.I., Rapoport J.L., and Grady C.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiat 49 (1992) 690-694
322. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A., Friedland R., Rapoport S.I., and Rapoport J.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiat 46 (1989) 518-523
323. Swerdlow N.R., and Koob G.F. Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci 10 (1987) 197-245
324. Takada M., Ng G., and Hattori T. Single pallidal neurons project to both the striatum and the thalamus in the rat. Neurosci Lett 69 (1986) 217-220
325. Tallaksen-Greene S.J., and Albin R. Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience 75 (1996) 1057-1064
326. Tepper J.M., Sun B.C., Martin L.P., and Creese I. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 17 (1997) 2519-2530
327. Testa C., Friberg I., Weiss S., and Standaert D. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J Comp Neurol 390 (1998) 5-19
328. Testa C.M., Standaert D.G., Landwehrmeyer G.B., Penney Jr. J.B., and Young A.B. Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons. J Comp Neurol 354 (1995) 241-252
329. Testa C.M., Standaert D.G., Young A.B., and Penney J.B. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci 14 (1994) 3005-3018
330. Thoss V.S., Perez J., Probst A., and Hoyer D. Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Naunyn Schmiedeberg's Arch. Pharmacol 354 (1996) 411-419
331. Tretter V., Ehya N., Fuchs K., and Sieghart W. Stoichiometry and assembly of a recombinant GABAA receptor subtype. J Neurosci 17 (1997) 2728-2737
332. 14C]-2-deoxyglucose autoradiography. Prog. Neuropsychopharmacol Biol Psychiat 19 (1995) 795-810
333. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350 (1991) 610-614
334. Vonsattel J.-P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Hungtington's disease. J Neuropathol Exp Neurol 44 (1985) 559-577
335. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., and Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284 (1989) 314-335
336. Waeber C., and Palacios J.M. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia. Mol Brain Res 24 (1994) 199-209
337. Waeber C., Rigo M., Chinaglia G., Probst A., and Palacios J.M. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease. Synapse 8 (1991) 270-280
338. Walker F.O., Young A.B., Penney J.B., Dovorini-Zis K., and Shoulson I. Benzodiazepine and GABA receptors in early Huntington's disease. Neurology 34 (1984) 1237-1240
339. Walker J.E., Saraste M., Runswick M.J., and Gay N.J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1 (1982) 945-951
340. Walker R.W., Arbuthnott G.W., Baughman R.W., and Graybiel A.M. Dendritic domains of medium spiny neurons in the primate striatum: Relationships to striosomal borders. J Comp Neurol 337 (1993) 614-628
341. Walker R.W., and Graybiel A.M. Dendritic arbors of spiny neurons in the primate striatum are directionally polarized. J Comp Neurol 337 (1993) 629-639
342. Waters C.H., Faust P.L., Powers J., Vinters H., Moskowitz C., Nygaard
343. White N.M. Mnemonic functions of the basal ganglia. Curr Opin Neurobiol 7 (1997) 164-169
344. Whitehouse P.J., Trifiletti R.R., Jones B.E., Folstein S., Price D.L., Snyder S.H., and Kuhar M.J. Neurotransmitter receptor alterations in Hungtington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes. Ann Neurol 18 (1985) 202-210
345. Whitty C.J., Paul M.A., and Bannon M.J. Neurokinin receptor mRNA localization in human midbrain dopamine neurons. J Comp Neurol 382 (1997) 394-400
346. Wichmann T., Bergman H., and DeLong M.R. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 72 (1994) 494-506
347. Wichmann T., Bergman H., and DeLong M.R. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J Neurophysiol 72 (1994) 521-530
348. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 6 (1996) 751-758
349. Wichmann T., and DeLong M.R. Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg Clin N Am 9 (1998) 223-236
350. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12 (1992) 1040-1062
351. Wolf S.S., Jones D.W., Knable M.B., Gorey J.G., Lee K.S., Hyde T.M., Coppola R., and Weinberger D.R. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273 (1996) 1225-1227
352. Wullner U., Testa C.M., Catania M.V., Young A.B., and Penney Jr. J.B. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res 645 (1994) 98-102
353. Xu M., Koeltzow T.E., Santiago G.T., Moratalla R., Cooper D.C., Hu X.-T., White N.M., Graybiel A.M., White F.J., and Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19 (1997) 837-848
354. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., and Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79 (1994) 729-742
355. Young A.B., Penney J.B., Cha J.J., Olsen J.M.M., Greenamyre J.T., Albin R., and Richfield E.K. Neuronal and anatomical localization of excitatory amino acid receptor subtypes in vertebrate brain. In: Cavalheiro E.A., Lehmann J., and Turski L. (Eds). Frontiers in Excitatory Amino Acid Research (1988), Alan R Liss, New York 109-115
356. Young A.B., Penney J.B., Dauth G.W., Bromberg M.B., and Gilman S. Glutamate or aspartate as a possible neurotransmitter of cerebral corticofugal fibers in the monkey. Neurology 33 (1983) 1513-1516
357. Young A.B., Penney J.B., Starosta-Rubinstein S., Markel D.S., Berent S., Giordani B., Ehrenkaufer R., Jewett D., and Hichwa R. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 20 (1986) 296-303
358. Young A.B., Shoulson I., Penney J.B., Starosta-Rubinstein S., Gomez F., Travers H., Ramos-Arroyo M.A., Snodgrass S.R., Bonilla E., Moreno H., and Wexler N.H. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 36 (1986) 244-249
359. Young A.B., and Snyder S.H. Strychnine binding associated with glycine receptors of the central nervous system. Proc Natl Acad Sci USA 70 (1973) 2832-2836
360. 3H]opioid receptors in rat brain. Brain Res 179 (1979) 255-270